Ame Company For Medical Supplies
TADAWUL:9527.SR
93 (SAR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 133.819 | 102.981 | 54.171 | 84.823 | 54.057 | 81.603 | 37.622 |
| Cost of Revenue
| 76.22 | 60.743 | 28.99 | 43.878 | 27.417 | 44.373 | 20.792 |
| Gross Profit
| 57.599 | 42.238 | 25.181 | 40.945 | 26.641 | 37.23 | 16.829 |
| Gross Profit Ratio
| 0.43 | 0.41 | 0.465 | 0.483 | 0.493 | 0.456 | 0.447 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 3.903 | 0 | 3.32 | 0 | 4.396 | 0 | 2.888 |
| Selling & Marketing Expenses
| 10.827 | 0 | 10.729 | 0 | 10.332 | 0 | 7.305 |
| SG&A
| 29.821 | 29.77 | 14.048 | 28.224 | 14.728 | 20.522 | 10.192 |
| Other Expenses
| -5.801 | -0 | 0 | 0 | 0 | -1.07 | 0 |
| Operating Expenses
| 29.821 | 29.77 | 15.12 | 28.224 | 16.357 | 21.592 | 14.149 |
| Operating Income
| 27.778 | 12.468 | 10.06 | 12.721 | 10.284 | 15.638 | 2.68 |
| Operating Income Ratio
| 0.208 | 0.121 | 0.186 | 0.15 | 0.19 | 0.192 | 0.071 |
| Total Other Income Expenses Net
| 0.999 | 0.76 | -0.056 | 0.116 | -0.029 | -0.282 | -0.048 |
| Income Before Tax
| 28.776 | 13.228 | 10.004 | 12.836 | 10.255 | 15.356 | 2.632 |
| Income Before Tax Ratio
| 0.215 | 0.128 | 0.185 | 0.151 | 0.19 | 0.188 | 0.07 |
| Income Tax Expense
| 2.184 | 1.909 | 0.81 | 1.529 | 0.75 | 1.632 | 0.712 |
| Net Income
| 26.593 | 11.319 | 9.194 | 11.307 | 9.505 | 13.725 | 1.92 |
| Net Income Ratio
| 0.199 | 0.11 | 0.17 | 0.133 | 0.176 | 0.168 | 0.051 |
| EPS
| 3.8 | 1.62 | 3.17 | 1.62 | 1.36 | 1.96 | 0.27 |
| EPS Diluted
| 3.8 | 1.62 | 3.17 | 1.62 | 1.36 | 1.96 | 0.27 |
| EBITDA
| 28.725 | 13.292 | 10.06 | 13.199 | 10.284 | 15.952 | 2.68 |
| EBITDA Ratio
| 0.215 | 0.129 | 0.186 | 0.156 | 0.19 | 0.195 | 0.071 |